Literature DB >> 22736713

Global longitudinal strain is a strong independent predictor of all-cause mortality in patients with aortic stenosis.

L G Kearney1, K Lu, M Ord, S K Patel, K Profitis, G Matalanis, L M Burrell, P M Srivastava.   

Abstract

AIMS: To assess the capacity of global longitudinal strain (GLS) in patients with aortic stenosis (AS) to (i) detect the subclinical left ventricular (LV) dysfunction [LV ejection fraction (LVEF) ≥50% patients]; (ii) predict all-cause mortality and major adverse cardiac events (MACE) (all patients), and (iii) provide incremental prognostic information over current risk markers. METHODS AND
RESULTS: Patients with AS (n = 146) and age-matched controls (n = 12) underwent baseline echocardiography to assess AS severity, conventional LV parameters and GLS via speckle tracking echocardiography. Baseline demographics, symptom severity class and comorbidities were recorded. Outcomes were identified via hospital record review and subject/physician interview. The mean age was 75 ± 11, 62% were male. The baseline aortic valve (AV) area was 1.0 ± 0.4 cm(2) and LVEF was 59 ± 11%. In patients with a normal LVEF (n = 122), the baseline GLS was controls -21 ± 2%, mild AS -18 ± 3%, moderate AS -17 ± 3% and severe AS -15 ± 3% (P< 0.001). GLS correlated with the LV mass index, LVEF, AS severity, and symptom class (P< 0.05). During a median follow-up of 2.1 (inter-quartile range: 1.8-2.4) years, there were 20 deaths and 101 MACE. Unadjusted hazard ratios (HRs) for GLS (per %) were all-cause mortality (HR: 1.42, P< 0.001) and MACE (HR: 1.09, P< 0.001). After adjustment for clinical and echocardiographic variables, GLS remained a strong independent predictor of all-cause mortality (HR: 1.38, P< 0.001).
CONCLUSIONS: GLS detects subclinical dysfunction and has incremental prognostic value over traditional risk markers including haemodynamic severity, symptom class, and LVEF in patients with AS. Incorporation of GLS into risk models may improve the identification of the optimal timing for AV replacement.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22736713     DOI: 10.1093/ehjci/jes115

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  43 in total

1.  Improvements in global longitudinal strain after transcatheter aortic valve replacement according to race.

Authors:  Aamir H Twing; Brody Slostad; Christina Anderson; Sreenivas Konda; Elliott M Groves; Mayank M Kansal
Journal:  Am J Cardiovasc Dis       Date:  2021-04-15

Review 2.  Echocardiographic assessment of left ventricular systolic function.

Authors:  Lars Gunnar Klaeboe; Thor Edvardsen
Journal:  J Echocardiogr       Date:  2018-11-02

3.  Global myocardial longitudinal strain in a general population-associations with blood pressure and subclinical heart failure: The Tromsø Study.

Authors:  Michael Stylidis; David A Leon; Assami Rӧsner; Henrik Schirmer
Journal:  Int J Cardiovasc Imaging       Date:  2019-12-18       Impact factor: 2.357

4.  Improvement of left ventricular longitudinal systolic function after transcatheter aortic valve implantation: a speckle-tracking prospective study.

Authors:  Flavio D'Ascenzi; Matteo Cameli; Alessandro Iadanza; Matteo Lisi; Valerio Zacà; Rosanna Reccia; Valeria Curci; Andrea Torrisi; Giuseppe Sinicropi; Carlo Pierli; Sergio Mondillo
Journal:  Int J Cardiovasc Imaging       Date:  2012-12-28       Impact factor: 2.357

5.  Incremental value of global longitudinal strain in prediction of all-cause mortality in predialysis and dialysis chronic kidney disease patients.

Authors:  Ivana Valocikova; Marianna Vachalcova; Gabriel Valocik; Marian Kurecko; Mariana Dvoroznakova; Peter Mitro; Jozefina Cocherova; Stanislava Buday Bujnakova; Dusan Holoubek
Journal:  Wien Klin Wochenschr       Date:  2016-03-14       Impact factor: 1.704

6.  Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain.

Authors:  Marit Kristine Smedsrud; Jørgen Gravning; Torbjørn Omland; Christian Eek; Lars Mørkrid; Helge Skulstad; Lars Aaberge; Bjørn Bendz; John Kjekshus; Thor Edvardsen
Journal:  Int J Cardiovasc Imaging       Date:  2015-03-19       Impact factor: 2.357

7.  Reduced Left Ventricular Global Longitudinal Strain Predicts Prolonged Hospitalization: A Cohort Analysis of Patients Having Aortic Valve Replacement Surgery.

Authors:  Abraham Sonny; Andrej Alfirevic; Shiva Sale; Nicole M Zimmerman; Jing You; A Marc Gillinov; Daniel I Sessler; Andra E Duncan
Journal:  Anesth Analg       Date:  2018-05       Impact factor: 5.108

8.  Improving risk assessment for post-surgical low cardiac output syndrome in patients without severely reduced ejection fraction undergoing open aortic valve replacement. The role of global longitudinal strain and right ventricular free wall strain.

Authors:  K Balderas-Muñoz; H Rodríguez-Zanella; J F Fritche-Salazar; N Ávila-Vanzzini; L E Juárez Orozco; J A Arias-Godínez; O Calvillo-Argüelles; S Rivera-Peralta; J C Sauza-Sosa; M E Ruiz-Esparza; E Bucio-Reta; A Rómero; N Espinola-Zavaleta; B Domínguez-Mendez; M Gaxiola-Macias; M A Martínez-Ríos
Journal:  Int J Cardiovasc Imaging       Date:  2017-05-09       Impact factor: 2.357

Review 9.  Challenges and opportunities in improving left ventricular remodelling and clinical outcome following surgical and trans-catheter aortic valve replacement.

Authors:  Xu Yu Jin; Mario Petrou; Jiang Ting Hu; Ed D Nicol; John R Pepper
Journal:  Front Med       Date:  2021-05-28       Impact factor: 4.592

10.  Association of Left Ventricular Global Longitudinal Strain With Asymptomatic Severe Aortic Stenosis: Natural Course and Prognostic Value.

Authors:  E Mara Vollema; Tadafumi Sugimoto; Mylène Shen; Lionel Tastet; Arnold C T Ng; Rachid Abou; Nina Ajmone Marsan; Bart Mertens; Raluca Dulgheru; Patrizio Lancellotti; Marie-Annick Clavel; Philippe Pibarot; Philippe Genereux; Martin B Leon; Victoria Delgado; Jeroen J Bax
Journal:  JAMA Cardiol       Date:  2018-09-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.